Medicare Enrolled
Dr. Rene Celis, MD
Interventional Cardiology · Daytona Beach, FL
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Celis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Celis? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Celis
Dr. Rene Celis is an interventional cardiology in Daytona Beach, FL, with 17 years in practice. Based on federal Medicare data, Dr. Celis performed 2,355 Medicare services across 1,601 unique beneficiaries.
Between the years covered by Open Payments, Dr. Celis received a total of $16,301 from 59 pharmaceutical and/or device companies across 564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Celis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 45% volume in FL$ $16,301 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,355
Medicare services
Top 45% in FL for interventional cardiology
1,601
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~139 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 445 | $95 | $262 |
| Office visit, established patient, complex (40-54 min) | 278 | $138 | $310 |
| Electrocardiogram (EKG), 12-lead | 271 | $10 | $31 |
| EKG interpretation and report | 159 | $6 | $25 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 153 | $27 | $82 |
| New patient office visit (45-59 min) | 131 | $117 | $312 |
| Office visit, established patient (20-29 min) | 124 | $56 | $160 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 119 | $20 | $50 |
| Hospital follow-up visit, moderate complexity | 74 | $63 | $169 |
| Remote pacemaker/defibrillator monitoring, 90 days | 58 | $15 | $50 |
| Regadenoson injection (Lexiscan) for heart stress test | 57 | $32 | $160 |
| Hospital follow-up visit, low complexity | 45 | $40 | $107 |
| Echocardiogram, transthoracic | 43 | $142 | $473 |
| Remote pacemaker monitoring, 90 days | 42 | $21 | $56 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 42 | $10 | $102 |
| Initial hospital admission, moderate complexity | 42 | $103 | $303 |
| New patient office visit (30-44 min) | 36 | $52 | $170 |
| Initial hospital admission, high complexity | 32 | $137 | $395 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 28 | $627 | $1,299 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 22 | $50 | $172 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 22 | $351 | $1,100 |
| Programming of single lead pacemaker system | 20 | $52 | $148 |
| Programming of dual lead pacemaker system | 19 | $61 | $161 |
| Programming of cardiac rhythm monitor system | 16 | $43 | $82 |
| New patient office visit, complex (60-74 min) | 16 | $162 | $420 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $82 | $352 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $332 | $1,058 |
| Cardiac catheterization | 12 | $236 | $1,640 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 12 | $66 | $193 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $18 | $47 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
4.5% medium
87.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,301
Total received (2018-2024)
Avg $2,329/year across 7 years
Top 33% in FL for interventional cardiology
59
Companies
564
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,285 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,165
2023$2,221
2022$2,114
2021$1,541
2020$1,235
2019$2,460
2018$3,565
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,782
Cardiovascular Systems Inc.
$1,593
Abbott Laboratories
$1,515
ABIOMED
$1,263
Medtronic Vascular, Inc.
$1,135
Boehringer Ingelheim Pharmaceuticals, Inc.
$823
Novartis Pharmaceuticals Corporation
$723
Janssen Pharmaceuticals, Inc
$714
Amgen Inc.
$703
CVRx, Inc.
$585
Boston Scientific Corporation
$498
PFIZER INC.
$403
SANOFI-AVENTIS U.S. LLC
$329
Stryker Corporation
$329
Cleerly, Inc.
$323
W. L. Gore & Associates, Inc.
$322
Merck Sharp & Dohme LLC
$281
Penumbra, Inc.
$276
Amarin Pharma Inc.
$226
AstraZeneca Pharmaceuticals LP
$217
Novo Nordisk Inc
$165
E.R. Squibb & Sons, L.L.C.
$153
ATRICURE, INC.
$150
Kestra Medical Technology Services, Inc.
$148
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$126
Inari Medical, Inc.
$118
Merck Sharp & Dohme Corporation
$115
Philips North America LLC
$88
Chiesi USA, Inc.
$86
Impulse Dynamics (USA) Inc.
$84
Actelion Pharmaceuticals US, Inc.
$83
Philips Electronics North America Corporation
$81
Kowa Pharmaceuticals America, Inc.
$80
Esperion Therapeutics, Inc.
$70
ARBOR PHARMACEUTICALS, INC.
$66
BIOTRONIK INC.
$61
BOSTON SCIENTIFIC CORPORATION
$56
Cook Medical LLC
$54
Braemar Manufacturing, LLC
$49
Bayer HealthCare Pharmaceuticals Inc.
$35
Teleflex LLC
$34
AngioDynamics, Inc.
$29
Alnylam Pharmaceuticals Inc.
$29
Gilead Sciences, Inc.
$28
Edwards Lifesciences Corporation
$28
ACIST MEDICAL SYSTEMS, INC.
$27
Lexicon Pharmaceuticals, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$22
AtriCure, Inc.
$20
Aegerion Pharmaceuticals, Inc.
$19
Astellas Pharma US Inc
$18
Amryt Pharma Holdings Ltd
$18
Regeneron Healthcare Solutions, Inc.
$17
Avinger Inc.
$16
BSN Medical Inc
$16
Arbor Pharmaceuticals, Inc.
$13
BRACCO DIAGNOSTICS INC.
$13
ZOLL Circulation Inc
$12
Bardy Diagnostics, Inc.
$12
Top 3 companies account for 30.0% of total payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (BS0) Mechanical Atherectomy · (CM9) Amb Mon & Diag Und · ABRE · ACUSEAL Vascular Graft · ALPHAVAC · AMPLATZER AMULET · AMPLATZER TALISMAN · ANGIOJET · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · AZURE XT DR MRI SURESCAN · Advisa · Amplia MRI · Arcalyst · Assure WCD · Attain · Azure · BRILINTA · Barostim Neo System · CARDIOGEN · CARDIOMEMS · CHANTIX · CLOSUREFAST · COREVALVE EVOLUT R · CVI SYSTEMS · Cardiac Monitoring Suite · CareLink · Carnation Ambulatory Monitor · Claria MRI · Cleerly Ischemia · Concerto · Cook Celect · Cook Medical Celect Platinum · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVERCROSS · EXCLUDER Iliac Branch Endoprosthesis · Edarbi · Edarbyclor · EverFlex · FARXIGA · FLOWTRIEVER CATHETER · GORE EXCLUDER Iliac Branch Endoprosthesis · GORE VIABAHN Endoprosthesis with Heparin · General - Therapies · General - Vascular Access · HAWKONE · HOFFMANN · HawkOne · IGT D Peripheral · IGT_D Peripheral · IN.PACT ADMIRAL · Impella · Indigo · Indigo System · JARDIANCE · JETI · JETI PERIPHERAL CATHETER · JOBST SPORT · JUXTAPID · KENGREAL · Kerendia · LEQVIO · LEXISCAN · Launcher · LifeVest · Livalo · MICRA · MULTAQ · Manta · Micra · Mitra Clip system · MitraClip System · NEXLETOL · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PANTHERIS · PERCLOSE PROGLIDE · PRADAXA · PRALUENT · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · RESOLUTE ONYX · RXI SYSTEMS · Repatha · Resolute · Reveal LINQ · Rybelsus · S · SAPIEN 3 Ultra RESILIA · SPIDERFX · STIOLTO RESPIMAT · Stellarex · TRAPLINER · TherOx DS2 Console · UPTRAVI · VERQUVO · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with Heparin Bioactive Surface · VIABAHN Endoprosthesis with PROPATEN Bioactive Surface · VIABAHN VBX Balloon Expandable Endoprosthesis · VIATORR Endoprosthesis · VYNDAQEL · Varithena Administration Pack · Vascepa · WALLSTENT · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $692 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
15
Per 100K population
2.6
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Celis is a electrophysiology & remote specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Celis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Celis performed 445 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Celis receive payments from pharmaceutical companies?
Yes. Dr. Celis received a total of $16,301 from 59 companies across 564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Celis's costs compare to other interventional cardiologys in Daytona Beach?
Dr. Celis's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Celis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Daytona Beach
Browse interventional cardiologys in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in FL
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in FL
Which FL interventional cardiologys receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology